Effects of testis polypeptides on sperm parameters and sperm DNA fragmentation index in patients with male infertility

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Aim. To evaluate the effect of a drug based on bovine testicular polypeptides (Testiwell) on sperm parameters and sperm DNA fragmentation index in patients with idiopathic male infertility.

Materials and methods. A total of 100 men with a diagnosis of infertility were included in the study. They received Testiwell intramuscularly once a week for 10 weeks. Before and after treatment, basic sperm parameters according to WHO criteria and sperm DNA fragmentation index using the TUNEL method were assessed. Statistical analysis included Shapiro-Wilk, Wilcoxon, paired Student's t-test, and McNemar's test.

Results. The median age of patients was 32 years. Significant improvement was noted in the proportion of morphologically normal sperm (p<0.001), concentration of morphologically normal sperm (from 1.16 to 1.55 million/ml, p=0.048). A decrease in sperm DNA fragmentation index was observed (from 20.8% to 17.8%, p<0.001), a reduction in the frequency of oligozoospermia from 34% to 22% (p=0.0047), and a decrease in the proportion of patients with increased DNA fragmentation index from 79% to 67% (p=0.0013). In patients with oligozoospermia at baseline, the median increase in concentration was 142%, while in those with asthenozoospermia an increase in motility by 77% was seen, and in men with high levels of DNA fragmentation, a decrease in DNA fragmentation index by 15.5% was found.

Discussion. Testiwell demonstrated the ability to positively influence not only quantitative but also qualitative sperm parameters, including morphology and sperm DNA fragmentation. Proposed mechanisms of action include regulation of protamination, reduction of apoptosis, and immunologically mediated effects on sperm maturation. The obtained data are consistent with previously described effects of polypeptide drugs in preclinical models and expand the possibilities of using the Testiwell for various forms of male infertility, including assisted reproduction techniques failures.

Conclusion. Testiwell significantly improves morphological and molecular parameters of spermatogenesis in patients with male infertility. It can be used both in the basic therapy of idiopathic infertility and, possibly, in cases of miscarriage and inefficiency of assisted reproduction techniques.


Full Text

Restricted Access

About the authors

Safar I. Gamidov

National Medical Research Center of Obstetrics, Gynecology and Perinatology named after V.I. Kulakov of the Ministry of Health of Russia; I.M. Sechenov First Moscow State Medical University of the Ministry of Health of Russia (Sechenov University)

Email: safargamidov@yandex.ru
ORCID iD: 0000-0002-9128-2714

Ph.D., MD, Professor of the Department of Obstetrics, Gynecology, Perinatology and Reproductology of I.M. Sechenov First Moscow State Medical University of the Ministry of Health of Russia (Sechenov University), Head of the Department of Andrology and Urology of National Medical Research Center of Obstetrics, Gynecology and Perinatology named after V.I. Kulakov of the Ministry of Health of Russia

Russian Federation, 117997, Moscow, Academician Oparin St., 4; 119048, Moscow, Trubetskaya St., 8, bldg. 2

Alina Yu. Popova

National Medical Research Center of Obstetrics, Gynecology and Perinatology named after V.I. Kulakov of the Ministry of Health of Russia

Email: alina-dock@yandex.ru
ORCID iD: 0000-0003-1163-5602

Ph.D., urologist at the Department of Andrology and Urology 

Russian Federation, 117997, Moscow, Academician Oparin St., 4

Taras V. Shatylko

National Medical Research Center of Obstetrics, Gynecology and Perinatology named after V.I. Kulakov of the Ministry of Health of Russia

Author for correspondence.
Email: dialectic.law@gmail.com
ORCID iD: 0000-0002-3902-9236

Ph.D., urologist at the Department of Andrology and Urology 

Russian Federation, 117997, Moscow, Academician Oparin St., 4

Ramazan U. Mammaev

National Medical Research Center of Obstetrics, Gynecology and Perinatology named after V.I. Kulakov of the Ministry of Health of Russia; I.M. Sechenov First Moscow State Medical University of the Ministry of Health of Russia (Sechenov University)

Email: ramazan.mammaev@outlook.com
ORCID iD: 0000-0002-7374-7020

Ph.D. student at the Department of Obstetrics, Gynecology, Perinatology and Reproductology of I.M. Sechenov First Moscow State Medical University of the Ministry of Health of Russia (Sechenov University)

Russian Federation, 117997, Moscow, Academician Oparin St., 4; 119048, Moscow, Trubetskaya St., 8, bldg. 2

References

  1. Efremov E.A., Kasatonova E.V. Current and promising methods of idiopathic male infertility treatment. Andrologiya i genital’naya khirurgiya = Andrology and Genital Surgery. 2022;23(3):48–53. doi: 10.17650/2070 9781-2022-23-3-48-53. Russian (Ефремов Е.А., Касатонова Е.В. Актуальные и перспективные методы лечения идиопатического мужского бесплодия. Андрология и генитальная хирургия 2022;23(3):48–53. doi: 10.17650/2070-9781-2022 23-3-48-53)
  2. Minhas S, Boeri L, Capogrosso P, Cocci A, Corona G et al. European Association of Urology Guidelines on Male Sexual and Reproductive Health: 2025 Update on Male Infertility. Eur Urol. 2025;87(5):601-616. doi: 10.1016/j.eururo.2025.02.026. Epub 2025 Mar 20. PMID: 40118737.
  3. Apollichin O.I., Babenko A.Y,, Bogolubov C.V., Bozhedomov V.A. et al. Clinical guidelines «Male Infertility». Russian Society of Urology. M., 2025. Russain (Аполихин О.И., Бабенко А.Ю., Боголюбов С.В., Божедомов В.А. и соавт. Клинические рекомендации «Мужское бесплодие». Российское общество урологов. M., 2025).
  4. Shatylko T.V., Gamidov S.I., Naumov N.P., Popova A.Y. Standardization of Terms in Reproductive Andrology: Searching for Consensus. Andrology and Genital Surgery. 2024;25(2):80–85. doi: 10.62968/2070-9781-2024-25-2-80-85. Russian (Шатылко Т.В., Гамидов С.И., Наумов Н.П., Попова А.Ю. Стандартизация терминов в репродуктивной андрологии: поиск консенсуса. Андрология и генитальная хирургия. 2024;25(2):80–85. doi: 10.62968/2070-9781-2024-25-2-80-85.)
  5. Pushkar D.Y., Kupriyanov Y.A., Gamidov S.I., Teteneva A.V., Spivak L.G., Shormanov I.S. et al. Assessment of the safety and efficacy of medicinal product PPR-001 based on regulatory polypeptides of the testes. Urologiia. 2021;2021:100–108. https://doi.org/10.18565/urology.2021.6.100-108. Russian (Пушкарь Д.Ю., Куприянов Ю.А., Берников А.Н., Гамидов С.И., Тетенева А.В., Спивак Л.Г., Шорманов И.С., Новиков А.И., Аль-Шукри С.Х., Богдан Е.Н., Щукин В.Л., Борискин А.Г. Оценка безопасности и эффективности лекарственного препарата на основе регуляторных полипептидов семенников PPR-001. Урология. 2021;6:100–108. Doi: https: //dx.doi.org/10.18565/urology.2021.6.100-108).
  6. Spivak L.G., Gamidov S.I., Al-Shukri S.H., Morozov A.O., Androsov A.A., Popova A.Yu., Kupriyanov Yu.A., Pushkar D.Yu. Evaluation of long-term results of using the drug Fertiwell: impact on the likelihood of conception and pregnancy outcome. Urologiia. 2023;6:73–79. Doi: https: //dx.doi.org/10.18565/urology.2023.6.73-79. Russian (Спивак Л.Г., Гамидов С.И., Аль-Шукри С.Х., Морозов А.О., Андросов А.А., Попова А.Ю., Куприянов Ю.А., Пушкарь Д.Ю. Оценка отдаленных результатов применения препарата Фертивелл: влияние на вероятность зачатия и исход беременности. Урология. 2023;6:73–79. Doi: https: //dx.doi.org/10.18565/urology.2023.6.73-79).
  7. Shatylko T.V., Mammaev R.U., Gamidov S.I., Makarova N.P. et al. Dynamics of Ejaculate Parameters from 2017 to 2023: a Retrospective Single-Center Analysis. Andrology and Genital Surgery. 2024;25(2):54–60. doi: 10.62968/2070-9781-2024-25-2-54-60. Russian (Шатылко Т.В., Маммаев Р.У., Гамидов С.И., Макарова Н.П. и соавт. Динамика показателей эякулята за период с 2017 по 2023 г.: ретроспективный одноцентровой анализ. Андрология и генитальная хирургия. 2024;25(2):54–60. doi: 10.62968/2070-9781-2024-25-2-54-60.)
  8. Korneyev I.A. Annual trends in semen parameters among men attending a fertility center between 2016 and 2022. Urology reports (St.-Petersburg). 2023:13(1):23-29. doi: 10.17816/uroved296569. Russian (Корнеев И.А. Сравнительная характеристика параметров эякулята мужчин, обратившихся в центр репродуктивной медицины с 2016 по 2022 г. Урологические ведомости. 2023:13(1):23–29. doi: 10.17816/uroved296569)
  9. Muradyan A.A., Gamidov S.I., Popova A.U., Ovchinnikov R.I. et al. Relationship Between Seminal Plasma Cytokine Levels and Asthenozoospermia in Infertile Men. Andrology and Genital Surgery. 2023;24(1):150–156. doi: 10.17650/2070-9781-2023-24-1-150-156. Russian (Мурадян А.А., Гамидов С.И., Попова А.Ю., Овчинников Р.И. Связь между уровнем цитокинов семенной плазмы и астенозооспермией у бесплодных мужчин. Андрология и генитальная хирургия. 2023;24(1):150–156. doi: 10.17650/2070-9781-2023-24-1-150-156.)
  10. Shatylko T.V., Gamidov S.I., Frankevich V.E., Starodubtseva N.L. et al. Asthenozoospermia and Proteomic Factors Regulating Sperm Motility. Obstetrics and Gynecology. 2020;4:37–44. doi: 10.18565/aig.2020.4.37-44. Russian (Шатылко Т.В., Гамидов С.И., Франкевич В.Е., Стародубцева Н.Л. и соавт. Астенозооспермия и протеомные факторы регуляции подвижности сперматозоидов. Акушерство и гинекология. 2020;4:37–44. doi: 10.18565/aig.2020.4.37-44).
  11. Le Foll N., Pont JC., L’Hostis A., Guilbert T. et al. Cyclic FEE Peptide Improves Human Sperm Movement Parameters without Modification of Their Energy Metabolism. Int J Mol Sci. 2021;22(20):11263. doi: 10.3390/ijms222011263.
  12. Khochenkova Yu.A, Machkova Yu.S., Khochenkov D.A., Sidorova T.A. et al. A Study of the Mechanisms of Action Of Fertiwell in Vivo. Urologiia. 2023;1:60–70. doi: 10.18565/urology.2023.1.60-70. Russian (Хоченкова Ю.А., Мачкова Ю.С., Хоченков Д.А., Сидорова Т.А. и соавт. Исследование механизмов действия препарата Фертивелл in vivo. Урология. 2023;1:60–70. doi: 10.18565/urology.2023.1.60-70.)
  13. Khochenkova Yu.A., Machkova Yu.S., Khochenkov D.A., Safarova E.R., Bastrikova N.A. Biological activity of a drug, polypeptides derived from testes in a model of oxidative stress in vitro. Experimental and Clinical Urology. 2022;15(3)18–26 https://doi.org/10.29188/2222-8543-2022-15-3-18-26. Russian (Хоченкова Ю.А., Мачкова Ю.С., Хоченков Д.А., Сафарова Э.Р., Бастрикова Н.А. Биологическая активность лекарственного препарата из полипептидов семенников в модели окислительного стресса in vitro. Экспериментальная и клиническая урология. 2022;15(3)18-26 https://doi.org/10.29188/2222-8543-2022-15-3-18-26).
  14. Rago V, De Rose D, Santoro M, Panza S et al. Human Sperm Express the Receptor for Glucagon-like Peptide-1 (GLP-1), Which Affects Sperm Function and Metabolism. Endocrinology. 2020;161(4):bqaa031. doi: 10.1210/endocr/bqaa031.
  15. Fraser LR. Modulation of mammalian sperm function by fertilization promoting peptide (FPP). Andrologia. 1998;30(4-5):241–47. doi: 10.1111/j.1439-0272.1998.tb01166.x.
  16. Fraser LR, Adeoya-Osiguwa SA. Fertilization promoting peptide--a possible regulator of sperm function in vivo. Vitam Horm. 2001;63:1–28. doi: 10.1016/s0083-6729(01)63001-2.
  17. Kumar V, Doshi G. Revolutionizing Infertility Management through Novel Peptide-based Targets. Curr Protein Pept Sci. 2024;25(9):738-752. doi: 10.2174/0113892037304433240430144106.
  18. Baker EG, Bartlett GJ, Porter Goff KL, Woolfson DN. Miniprotein Design: Past, Present, and Prospects. Acc Chem Res. 2017;50(9):2085-2092. doi: 10.1021/acs.accounts.7b00186.
  19. Ledesma A, Zalazar L, Buchelly Imbachi F, Pastore JI. et al. Recombinant peptide reverses cryo-capacitation in ram sperm and improves in vitro fertilization. Anim Reprod Sci. 2019;207:61–72. doi: 10.1016/j.anireprosci.2019.05.016.
  20. Li H, Huo Y, He X, Yao L et al. A male germ-cell-specific ribosome controls male fertility. Nature. 2022;612(7941):725-731. doi: 10.1038/s41586-022-05508-0.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download
2. Fig. Frequency of occurrence of spermiological syndromes before and after therapy, %

Download (58KB)
Indexing metadata

Copyright (c) 2025 Bionika Media